RT @RichardPAConway: Deodhar et al. Bimekizumab (IL-17A/Fi) in nr-axSpA. Efficacy shown across all outcomes. Confirms bi
Tweet Content
Deodhar et al. Bimekizumab (IL-17A/Fi) in nr-axSpA. Efficacy shown across all outcomes. Confirms bimekizumab works across spectrum of axSpA (not surprisingly). @RheumNow #ACR22 Abstr#0544 https://t.co/XVGBgBQpTH https://t.co/39zW5Ex9xh
Links
Bimekizumab Improves Signs and Symptoms, Including Inflammation, in Patients wi… https://acrabstracts.org/abstract/bimekizumab-improves-signs-and-symptoms-inclu…
Show on Archive Page
On
Display in Search Results
On
PDQ
Off